Abstract
This chapter provides guidelines for the consideration of medication treatment in very young children. It describes the careful assessment required, as well as the need to consider factors affecting the clinical context including access to care, rapid development, parent, child, and clinician attributes, and the limited evidence base. Prescribing practices and the evidence base to date for both pharmacologic and nonpharmacologic interventions are briefly reviewed. Diagnosis-Specific Approaches and Treatment Recommendations for Attention-Deficit Hyperactivity Disorder, Autism Spectrum Disorder, Anxiety, Posttraumatic Stress Disorder, Disorder of Dysregulated Anger and Aggression, Depression and Mood Problems, and Sleep Problems are Included.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AACAP. (2016). Autism spectrum disorders parents medication guide. Washington, DC: AACP.
AAP. (2011). ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. https://doi.org/10.1542/peds.2011-2654
AAP Committee on Drugs. (2002). Uses of drugs not described in the package insert (off-label uses). Pediatrics, 110, 181–182.
Abikoff, H. B., Thompson, M., Laver-Bradbury, C., Long, N., Forehand, R. L., Miller Brotman, L., et al. (2015). Parent training for preschool ADHD: A randomized controlled trial of specialized and generic programs. Journal of Child Psychology and Psychiatry, 56, 618–631.
APA. (2013). Diagnostic and Statistical Manual of Mental Disorders 5. Washington, DC: American Psychiatric Press.
Arnold, L. E., Vitiello, B., McDougle, C., Scahill, L., Shah, B., Gonzalez, N. M., et al. (2003). Parent-defined target symptoms respond to risperidone in RUPP autism study: Customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1443–1450. https://doi.org/10.1097/00004583-200312000-00011
Assael, B. M. (1999). Therapeutic orphans. European Perspective Pediatrics, 104, 591–592. https://doi.org/10.1542/peds.104.3.S1.591
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., et al. (2018). Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014. MMWR Surveillance Summaries, 67(SS-6), 1–23.
Barclay, R. P., Penfold, R. B., Sullivan, D., Boydston, L., Wignall, J., & Hilt, R. J. (2017). Decrease in statewide antipsychotic prescribing after implementation of child and adolescent psychiatry consultation services. Health Services Research, 52, 561–578.
Barterian, J. A., Rappuhn, E., Seif, E. L., Watson, G., Ham, H., & Carlson, J. S. (2014). Current state of evidence for medication treatment of preschool internalizing disorders. The Scientific World Journal, 2014, Article ID 286085.
Berger-Jenkins, E., McKay, M., Newcorn, J., Bannon, W., & Laraque, D. (2012). Parent medication concerns predict underutilization of mental health services for minority children with ADHD. Clinical Pediatrics (Phila), 51, 65–76.
Biederman, J., Mick, E., Hammerness, P., Harpold, T., Aleardi, M., Dougherty, M., et al. (2005). Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biological Psychiatry, 58, 589.
Birmaher, B., Brent, D. A., Chiappetta, L., Bridge, J., Monga, S., & Baugher, M. (1999). Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): A replication study. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1230–1236.
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. JAMA, 297, 1683–1696. https://doi.org/10.1001/jama.297.15.1683
Briggs-Gowan, M., & Carter, A. S. (2002). Brief Infant Toddler Social Emotional Assessment (BITSEA) Manual Version 2.0. New Haven, CT: Yale University.
Bufferd, S. J., Dougherty, L. R., Carlson, G. A., & Klein, D. N. (2011). Parent-reported mental health in preschoolers: Findings using a diagnostic interview. Comprehensive Psychiatry, 52, 359–369.
Bussing, R., Koro-Ljungberg, M. E., Gary, F., Mason, D. M., & Garvan, C. W. (2005). Exploring help-seeking for ADHD symptoms: A mixed-methods approach. Harvard Review of Psychiatry, 13, 85–101.
Bussing, R., Schoenberg, N. E., Rogers, K. M., Zima, B. T., & Angus, S. (1998). Explanatory models of ADHD: Do they differ by ethnicity, child gender, or treatment status? Journal of Emotional & Behavioral Disorders, 6, 233.
Carpenter, A. L., Puliafico, A. C., Kurtz, S. M., Pincus, D. B., & Comer, J. S. (2014). Extending parent–child interaction therapy for early childhood internalizing problems: New advances for an overlooked population. Clinical Child and Family Psychology Review, 17, 340.
CDC (2014). Retrieved January 4, 2017, from https://www.cdc.gov/ncbddd/adhd/infographics/treatments-preschool.html
Cesena M, Gonzalez-Heydrich J, Szigethy E,., Kohlenberg TM, DeMaso DR (2000) A case series of eight aggressive young children treated with risperidone. Journal of Child and Adolescent Psychopharmacology 12:337–345.
Charach, A., Dashti, B., Carson, P., Booker, L., Lim, C. G., Lillie, E., et al. (2012). Attention deficit hyperactivity disorder: Effectiveness of treatment in at-risk preschoolers; long-term effectiveness in all ages; and variability in prevalence, diagnosis, and treatment. York: Centre for Reviews and Dissemination.
Chirdkiatgumchai, V., Xiao, H., Fredstrom, B. K., Adams, R. E., Epstein, J. N., Shah, S. S., et al. (2013). National trends in psychotropic medication use in young children: 1994–2009. Pediatrics, 132, 615–623. https://doi.org/10.1542/peds.2013-1546
Choate, M. L., Pincus, D. B., & Eyberg, S. M. (2005). Parent-child interaction therapy for treatment of separation anxiety disorder in young children: A pilot study. Cognitive and Behavioral Therapy, 12, 136–145.
Choi, Y. K., Moran-Gates, T., Gardner, M. P., & Tarazi, F. I. (2010). Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats. European Neuropsychopharmacology, 20, 187–194.
Christensen, D. L., Bilder, D. A., Zahorodny, W., Pettygrove, S., Durkin, M. S., Fitzgerald, R. T., et al. (2016). Prevalence and characteristics of autism spectrum disorder among 4-year-old children in the autism and developmental disabilities monitoring network. Journal of Developmental and Behavioral Pediatrics, 37, 1–8. https://doi.org/10.1097/DBP.0000000000000235
Chubinsky, P., & Rappaport, N. (2006). Medication and the fragile alliance: The complex meanings of psychotropic medication to children, adolescents, and families. Journal of Infant, Child, and Adolescent Psychotherapy, 5, 111–123.
Coates, S., & Gaensbauer, T. J. (2009). Event trauma in early childhood: Symptoms, assessment, intervention. Child and Adolescent Psychiatric Clinics, 18, 611–626.
Cohen, J. A., Deblinger, E., Mannarino, A. P., & Steer, R. A. (2004). A multisite, randomized controlled trial for children with sexual abuse-related PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 393.
Cohen, J. A., Mannarino, A. P., Perel, J., & Staron, V. (2007). A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 811–819.
Comer, J. S., Puliafico, A. C., Aschenbrand, S. G., McKnight, K., Robin, J. A., Goldfine, M. E., et al. (2012). A pilot feasibility evaluation of the CALM Program for anxiety disorders in early childhood. Journal of Anxiety Disorders, 26, 40–49. https://doi.org/10.1016/j.janxdis.2011.08.011
Connor, D. F., Fletcher, K. E., & Swanson, J. M. (1999). A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1551–1559.
Copeland, W. E., Angold, A., Costello, E. J., & Egger, H. (2013). Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder. The American Journal of Psychiatry, 170, 173–179.
Coşkun, M., Öztürk, M., & Zoroğlu, S. (2012). Escitalopram treatment in preschool children with anxiety disorders: A case series. Bulletin of Clinical Psychopharmacology, 22, 262–267.
Coskun, M., & Zoroglu, S. (2009). Efficacy and safety of fluoxetine in preschool children with obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 19, 297–300. https://doi.org/10.1089/cap.2008.055
Costello, E. J., Farmer, E. M., Angold, A., Burns, B. J., & Erkanli, A. (1997). Psychiatric disorders among American Indian and white youth in Appalachia: The Great Smoky Mountains Study. American Journal of Public Health, 87, 827–832. https://doi.org/10.2105/ajph.87.5.827
Danielson, M. L., Visser, S. N., Gleason, M. M., Peacock, G., Claussen, A. H., & Blumberg, S. J. (2017). A national profile of attention-deficit hyperactivity disorder diagnosis and treatment among US children aged 2 to 5 years. Journal of Developmental and Behavioral Pediatrics, 38, 455–464.
Donovan, C. L., & March, S. (2014). Online CBT for preschool anxiety disorders: A randomised control trial. Behaviour Research and Therapy, 58, 24–35.
dosreis, S., Tai, M.-H., Goffman, D., Lynch, S. E., Reeves, G. M., & Shaw, T. (2014). Age-related trends in psychotropic medication use among very young children in foster care. Psychiatric Services, 65, 1452–1457.
dosReis, S., Yoon, Y., Rubin, D. M., Riddle, M. A., Noll, E., & Rothbard, A. (2011). Antipsychotic treatment among youth in foster care. Pediatrics, 128, e1459–e1466. https://doi.org/10.1542/peds.2010-2970
dosreis, S., Zito, J. M., Safer, D. J., & Soeken, K. L. (2001). Mental health services for youths in foster care and disabled youths. American Journal of Public Helath, 91, 1094–1099.
Dozier, M., Peloso, E., Lewis, E., Laurenceau, J. P., & Levine, S. (2008). Effects of an attachment-based intervention on the cortisol production of infants and toddlers in foster care. Development and Psychopathology, 20, 833–849.
Dummit, E. S., Klein, R. G., Asche, B., Martin, J., & Tancer, N. K. (1996). Fluoxetine treatment of children with selective mutism: An open trial. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 615–621.
Egger, H. L. (2010). A perilous disconnect: Antipsychotic drug use in very young children. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 3–6.
Egger, H. L., & Angold, A. (2006). Common emotional and behavioral disorders in preschool children: Presentation, nosology, and epidemiology. Journal of Child Psychology and Psychiatry, 47, 313–337.
Ercan, E. S., Basay, B. K., Basay, O., Durak, S., & Ozbaran, B. (2011). Risperidone in the treatment of conduct disorder in preschool children without intellectual disability. Child and Adolescent Psychiatry and Mental Health, 5. https://doi.org/10.1186/1753-2000-5-10
Ercan, E. S., Kandulu, R., & Akyol Ardic, U. (2012). Preschool children with obsessive-compulsive disorder and fluoxetine treatment. European Child & Adolescent Psychiatry, 21, 169–172. https://doi.org/10.1007/s00787-012-0244-2
Eyberg, S. M., Nelson, M. M., & Boggs, S. R. (2008). Evidence-based psychosocial treatments for children and adolescents with disruptive behavior. Journal of Clinical Child and Adolescent Psychology, 37, 215.
Eyberg, S. M., & Pincus, D. (1999). Eyberg Child Behavior Inventory & Sutter-Eyberg Student Behavior Inventory – Revised volume. Odessa, FL: Psychological Assessment Resources.
Fallucco, E. M., Wysocki, T., James, L., Kozikowski, C., Williams, A., & Gleason, M. M. (2017). The brief early childhood screening assessment: Preliminary validity in pediatric primary care. Journal of Developmental and Behavioral Pediatrics, 38, 89–98.
Faraone, S. V., Biederman, J., & Roe, C. (2002). Comparative efficacy of adderall and methylphenidate in attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Clinical Psychopharmacology, 22, 468–473.
Fardoulys, C., & Coyne, J. (2016). Circle of security intervention for parents of children with autism spectrum disorder. Australian and New Zealand Journal of Family Therapy, 37, 572–584.
Fiks, A. G., Mayne, S., DeBartolo, E., Power, T. J., & Guevara, J. P. (2013). Parental preferences and goals regarding ADHD treatment. Pediatrics. https://doi.org/10.1542/peds.2013-0152
Food and Drug Administration. (2002). Best pharmaceuticals for children act. Silver Spring, MD: FDA.
Franz, L., Angold, A., Copeland, W., Costello, E. J., Towe-Goodman, N., & Egger, H. (2013). Preschool anxiety disorders in pediatric primary care: Prevalence and comorbidity. Journal of the American Academy of Child and Adolescent Psychiatry, 52, 1294–1303. e1291.
Freeman, J., Sapyta, J., Garcia, A., Compton, S., Khanna, M., Flessner, C., et al. (2014). Family-based treatment of early childhood obsessive-compulsive disorder: The pediatric obsessive-compulsive disorder treatment study for young children (POTS Jr)—A randomized clinical trial. JAMA Psychiatry, 71, 689–698.
Garfield, L. D., Brown, D. S., Allaire, B. T., Ross, R. E., Nicol, G. E., & Raghavan, R. (2015). Psychotropic drug use among preschool children in the medicaid program from 36 states. American Journal of Public Health, 105, 524–529. https://doi.org/10.2105/ajph.2014.302258
Gleason, M. M., Dickstein, S., & Zeanah, C. H. (2010). Recognizing young children in need of mental health assessment: Development and preliminary validity of the Early Childhood Screening Assessment. Infant Mental Health Journal, 31, 1–22.
Gleason, M. M., Egger, H. L., Emslie, G. J., Greenhill, L. L., Kowatch, R. A., Lieberman, A. F., et al. (2007). Psychopharmacological treatment for very young children: Contexts and guidelines. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1532–1572.
Gleason, M. M., Goldson, E., Yogman, M. W., & Committee on Psychosocial Aspects of the Child. (2016a). Addressing early childhood emotional and behavioral problems (policy statement). Pediatrics, 138, e20163025.
Gleason, M. M., Goldson, E., Yogman, M. W., & Committee on Psychosocial Aspects of the Child. (2016b). Addressing early childhood emotional and behavioral problems: Technical report. Pediatrics, 138, e20163025.
Gleason, M. M. T., & Lauren, A. (2016). Updates on preschool psychopharmacological treatments. In J. Luby (Ed.), Handbook of preschool mental health. New York, NY: Guilford.
Greenhill, L. (1998a). The use of psychoactive medications in preschoolers: Indications, safety and efficacy. Canadian Journal of Psychiatry, 43, 576–581.
Greenhill, L., Kollins, S., Abikoff, H., McCracken, J., Riddle, M., Swanson, J., et al. (2006). Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 1284–1293.
Greenhill, L., Swanson, J., Vitiello, B., Davies, M., Clevenger, W., Wu, M., et al. (2001). Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 180–192.
Greenhill, L. L. (1998b). The use of psychotropic medication in preschoolers: Indications, safety and efficacy. Canadian Journal of Psychiatry, 43, 576–581.
Grzeskowiak, L. E., Morrison, J. L., Henriksen, T. B., Bech, B. H., Obel, C., Olsen, J., & Pedersen, L. H. (2016). Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort. BJOG: An International Journal of Obstetrics & Gynaecology, 123(12), 1919–1928.
Harmon, R. J., & Riggs, P. D. (1996). Clonidine for posttraumatic stress disorder in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1247–1249. https://doi.org/10.1097/00004583-199609000-00022
Harmon, R. J., & Riggs, P. D. (1999). Clonidine for posttraumatic stress disorder in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1247–1249.
Harvey, B., & Milne, M. (1998). Pharmacotherapy of selective mutism: Two case studies of severe entrenched mutism responsive to adjunctive treatment with fluoxetine. Southern African Journal of Child and Adolescent Mental Health, 10, 59–66.
Healthy Start Association. (2013). Retrieved March 19, 2018, from http://www.nationalhealthystart.org/healthy_start_initiative/project_directory. Accessed March
Hirota, T., Schwartz, S., & Correll, C. U. (2014). Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy. Journal of the American Academy of Child and Adolescent Psychiatry, 53, 153–173.
Hirshfeld-Becker, D. R., Masek, B., Henin, A., Blakely, L. R., Pollock-Wurman, R. A., McQuade, J., et al. (2010). Cognitive behavioral therapy for 4- to 7-year-old children with anxiety disorders: A randomized clinical trial. Journal of Consulting and Clinical Psychology, 78, 498–510.
Hoffman, K. T., Marvin, R. S., Cooper, G., & Powell, B. (2006). Changing toddlers’ and preschoolers’ attachment classifications: The circle of security intervention. Journal of Consulting and Clinical Psychology, 74, 1017.
Hood, K. K., & Eyberg, S. M. (2003). Outcomes of Parent-Child Interaction Therapy: Mothers’ Reports of Maintenance Three to Six Years After Treatment. Journal of Clinical Child and Adolescent Psychology, 32, 419–430.
Ingrassia, A., & Turk, J. (2005). The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders. European Child & Adolescent Psychiatry, 14, 34–40.
Kazdin, A. E. (2005). Parent management training: Treatment for oppositional, aggressive, and antisocial behavior in children and adolescents. New York, NY: Oxford University Press.
Kowatch, R. A., Scheffer, R. E., Monroe, E., Delgado, S., Altaye, M., & Lagory, D. (2015). Placebo-controlled trial of valproic acid versus risperidone in children 3–7 years of age with bipolar I disorder. Journal of Child and Adolescent Psychopharmacology, 25, 306–313.
Kratochvil, C. J., Egger, H., Greenhill, L. L., & McGough, J. J. (2006). Pharmacological management of preschool ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 115–118.
Kratochvil, C. J., Vaughan, B. S., Mayfield-Jorgensen, M. L., March, J. S., Kollins, S. H., Murray, D. W., et al. (2007). A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 17, 175–185.
Kratochvil, C. J., Vaughan, B. S., Stoner, J. A., Daughton, J. M., Lubberstedt, B. D., Murray, D. W., et al. (2011). A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. Pediatrics, 127, e862–e868. https://doi.org/10.1542/peds.2010-0825
Lawton, K. E., Gerdes, A. C., Haack, L. M., & Schneider, B. (2014). Acculturation, cultural values, and latino parental beliefs about the etiology of ADHD. Administration and Policy in Mental Health and Mental Health Services Research, 41, 189–204. https://doi.org/10.1007/s10488-012-0447-3
Lee, C. S., Williamson, L. R., Martin, S. E., DeMarco, M., Majczak, M., Martini, J., et al. (2015). Adverse events in very young children prescribed psychotropic medications: preliminary findings from an acute clinical sample. Journal of Child and Adolescent Psychopharmacology, 25, 509–513. https://doi.org/10.1089/cap.2015.0034
Lee, S. S., Lahey, B. B., Owens, E. B., & Hinshaw, S. P. (2008). Few preschool boys and girls with ADHD are well-adjusted during adolescence. Journal of Abnormal Child Psychology, 36, 373–383. https://doi.org/10.1007/s10802-007-9184-6
Licis, A. (2017). Sleep disorders: Assessment and treatment in preschool-aged children. Child and Adolescent Psychiatric Clinics, 26, 587–595.
Lieberman, A. F., Van Horn, P. J., & Ippen, C. G. (2005). Toward evidence-based treatment: Child-parent psychotherapy with preschoolers exposed to marital violence. Journal of the American Academy of Child & Adolescent Psychiatry, 44, 1241–11248.
Luby, J., Mrakotsky, C., Stalets, M. M., Belden, A., Heffelfinger, A., Williams, M., et al. (2006). Risperidone in preschool children with autistic spectrum disorders: An investigation of safety and efficacy. Journal of Child and Adolescent Psychopharmacology, 16, 575–587. https://doi.org/10.1089/cap.2006.16.575
Luby, J. L., & Belden, A. (2006). Defining and validating bipolar disorder in the preschool period. Development and Psychopathology, 18, 971–988.
Luby, J. L., Heffelfinger, A., Koenig-McNaught, A. L., Brown, K., & Spitznagel, E. (2004). The preschool feelings checklist: A brief and sensitive screening measure for depression in young children. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 708–716.
Luby, J. L., Lenze, S., & Tillman, R. (2011). A novel early intervention for preschool depression: Findings from a pilot randomized controlled trial. Journal of Child Psychology and Psychiatry, 53, 315–322. https://doi.org/10.1111/j.1469-7610.2011.02483.x
Magnusson, D. M., Minkovitz, C. S., Kuhlthau, K. A., Caballero, T. M., & Mistry, K. B. (2017). Beliefs regarding development and early intervention among low-income African American and Hispanic mothers. Pediatrics, 140. https://doi.org/10.1542/peds.2017-2059
Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008). Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121, e441–e448. https://doi.org/10.1542/peds.2007-0984
Maniadaki, K., Sonuga-Barke, E., Kakouros, E., & Karaba, R. (2007). Parental beliefs about the nature of ADHD behaviours and their relationship to referral intentions in preschool children. Child: Care, Health and Development, 33, 188–195.
Marcus, C. L., Brooks, L. J., Draper, K. A., Gozal, D., Halbower, A. C., Jones, J., et al. (2012). Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics, 130, 576–584.
Masi, G., Cosenza, A., Mucci, M., & Brovedani, P. (2003). A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone. Journal of Clinical Psychiatry, 64, 1039–1047.
Masse, J. J., McNeil, C. B., Wagner, S. M., & Chorney, D. B. (2007). Parent-child interaction therapy and high functioning autism: A conceptual overview. Journal of Early and Intensive Behavior Intervention, 4, 714.
McDonough, S. D. (2000). Interaction guidance: An approach for difficult-to-engage families. In C. H. Zeanah (Ed.), Handbook of infant mental health (2nd ed.). New York, NY: Guilford Press.
McMahon, R. J., & Forehand, R. L. (2005). Helping the noncompliant child: Family-based treatment for oppositional behavior. New York, NY: Guilford Press.
Merenstein, D., Diener-West, M., Halbower, A. C., Krist, A., & Rubin, H. R. (2006). The trial of infant response to diphenhydramine: The tired study—A randomized, controlled, patient-oriented trial. Archives of Pediatrics & Adolescent Medicine, 160, 707–712. https://doi.org/10.1001/archpedi.160.7.707
Mezzacappa, A., Lasica, P., Gianfagna, F., Cazas, O., Hardy, P., Falissard, B., et al. (2017). Risk for autism spectrum disorders according to period of prenatal antidepressant exposure: A systematic review and meta-analysis. JAMA Pediatrics, 171, 555–563. https://doi.org/10.1001/jamapediatrics.2017.0124
Mindell, J. A., Kuhn, B., Lewin, D. S., Meltzer, L. J., & Sadeh, A. (2006). Behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep, 29, 1263–1276.
Moll, G. H., Hause, S., Rüther, E., Rothenberger, A., & Huether, G. (2001). Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. Journal of Child and Adolescent Psychopharmacology, 11, 15–24. https://doi.org/10.1089/104454601750143366
Morgan, P. L., Staff, J., Hillemeier, M. M., Farkas, G., & Maczuga, S. (2013). Racial and ethnic disparities in ADHD diagnosis from kindergarten to eighth grade. Pediatrics, 132, 85–93. https://doi.org/10.1542/peds.2012-2390
Morgenthaler, T. I., Owens, J., Alessi, C., Boehlecke, B., Brown, T. M., Coleman Jr., J., et al. (2006). Practice parameters for behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep, 29, 1277–1281.
Murphy, J. M., Ichinose, C., Hicks, R. C., Kingdon, D., Crist-Whitzel, J., Jordan, P., et al. (1996). Utility of the pediatric symptom checklist as a psychosocial screen to meet the federal early and periodic screening, diagnosis, and treatment (EPSDT) standards: A pilot study. The Journal of Pediatrics, 129, 864.
Nagaraj, R., Singhi, P., & Malhi, P. (2006). Risperidone in children with autism: Randomized, placebo-controlled, double-blind study. Journal of Child Neurology, 21, 450.
Olfson, M., Crystal, S., Huang, C., & Gerhard, T. (2010). Trends in antipsychotic drug use by very young, privately insured children. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 13–23.
Olfson, M., King, M., & Schoenbaum, M. (2016). Stimulant treatment of young people in the United States. Journal of Child and Adolescent Psychopharmacology, 26, 520–526.
Oner, O., & Oner, P. (2008). Psychopharmacology of pediatric obsessive-compulsive disorder: Three case reports. Journal of Psychopharmacology, 22, 809–811. https://doi.org/10.1177/0269881107083362
Owens, J. A., Babcock, D., Blumer, J., Chervin, R., Ferber, R., Goetting, M., et al. (2006). The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: Rational approaches. A consensus meeting summary. Journal of Clinical Sleep Medicine, 1, 49–59.
Paul, I. M., Yoder, K. E., Crowell, K. R., Shaffer, M. L., McMillan, H. S., Carlson, L. C., et al. (2004). Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics, 114, e85–e90. https://doi.org/10.1542/peds.114.1.e85
Pavuluri, M. N., Henry, D. B., Carbray, J. A., Sampson, G. A., Naylor, M. W., & Janicak, P. G. (2006). A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 16, 336–350.
Pavuluri, M. N., Janicak, P. G., & Carbray, J. A. (2002). Topirimate plus risperidone for controlling weight gain and symptoms in preschool mania. Journal of Child and Adolescent Psychopharmacology, 12, 271–273.
Pennap, D., Burcu, M., Safer, D. J., & Zito, J. M. (2017). The impact of a state medicaid peer-review authorization program on pediatric use of antipsychotic medications. Psychiatric Services, 69(3), 293–299.
Prince, J. B., Wilens, T. E., Biederman, J., Spencer, T. J., & Wozniak, J. R. (1996). Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: A systematic chart review of 62 cases. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 599–605. https://doi.org/10.1097/00004583-199605000-00014
Rabbani, A., & Alexander, G. C. (2009). Impact of family structure on stimulant use among children with attention-deficit/hyperactivity disorder. Health Services Research, 44, 2060–2078.
Rachmiel, M., Johnson, T., & Daneman, D. (2006). Clonidine ingestion in children is not uneventful. The Journal of Pediatrics, 148, 850.
Robb, A. S., Cueva, J. E., Sporn, J., Yang, R., & Vanderburg, D. G. (2010). Sertraline treatment of children and adolescents with posttraumatic stress disorder: A double-blind, placebo-controlled trial. Journal of Child and Adolescent Psychopharmacology, 20, 463–471.
RUPP. (2005). Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Archives of General Psychiatry, 62, 1266–1174.
Russo, R. M., Gurara, V. J., & Allen, J. E. (1976). The effectiveness of diphenhydramine HCl in pediatric sleep disorders. Journal of Clinical Pharmacology, 16, 284–288.
Sanders, M. R., Baker, S., & Turner, K. M. T. (2012). A randomized controlled trial evaluating the efficacy of Triple P online with parents of children with early-onset conduct problems. Behaviour Research and Therapy, 50, 675–684. https://doi.org/10.1016/j.brat.2012.07.004
Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., et al. (2001). A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. The American Journal of Psychiatry, 158, 1067–1074. https://doi.org/10.1176/appi.ajp.158.7.1067
Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K., et al. (1997). Children’s Yale-Brown Obsessive Compulsive Scale: Reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 844–852. https://doi.org/10.1097/00004583-199706000-00023
Scheeringa MS (2002) Young child PTSD checklist. Retrieved January 4, 2017, from http://www.infantinstitute.org/MikeSPDF/YCPC_Aug2012.pdf. Accessed March 17 2018
Scheeringa, M. S., Salloum, A., Arnberger, R. A., Weems, C. F., Amaya-Jackson, L., & Cohen, J. A. (2007). Feasibility and effectiveness of cognitive-behavioral therapy for posttraumatic stress disorder in preschool children: Two case reports. Journal of Traumatic Stress, 20, 631–636.
Scheeringa, M. S., Weems, C. F., Cohen, J. A., Amaya-Jackson, L., & Guthrie, D. (2011). Trauma focused cognitive-behavioral treatment for posttraumatic stress disorder in three through six year-old children: A randomized clinical trial. Journal of Child Psychology and Psychiatry, 52, 853.
Scheffer, R. E., & Niskala, A. J. A. (2004). The diagnosis of preschool bipolar disorder presenting with mania: Open pharmacological treatment. Journal of Affective Disorders, 82, S25–S34.
Sheldrick, R. C., Henson, B. S., Merchant, S., Neger, E. N., Murphy, J. M., & Perrin, E. C. (2012). The preschool pediatric symptom checklist (PPSC): Development and initial validation of a new social/emotional screening instrument. Academic Pediatrics, 12, 456–467. https://doi.org/10.1016/j.acap.2012.06.008
Shonkoff, J. P., & Phillips, D. A. (2000). From neurons to neighborhoods: The science of early childhood development committee on integrating the science of early childhood development. Washington, D.C.: National Academy Press.
Short, E. J., Manos, M. J., Findling, R. L., & Schubel, E. A. (2004). A prospective study of stimulant response in preschool children: insights from ROC analyses. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 251–259.
Short, E. J., Manos, M. J., Findling, R. L. S., & Emily, A. (2004). A prospective study of stimulant response in preschool children: Insights from ROC analyses. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 251–259.
Smits, M. G., van Stel, H. F., van der Heijden, K., Meijer, A. M., Coenen, A. M. L., & Kerkhof, G. A. (2003). Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: A randomized placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1286–1293.
Spence, S. H., Rapee, R., McDonald, C., & Ingram, M. (2001). The structure of anxiety symptoms among preschoolers. Behaviour Research and Therapy, 39, 1293.
Staller, J. (2007). Psychopharmacologic treatment of aggressive preschoolers: A chart review. Journal of Neuropsychopharmacology and Biological Psychiatry, 31, 131–135.
Stein, B. D., Leckman-Westin, E., Okeke, E., Scharf, D. M., Sorbero, M., Chen, Q., et al. (2014). The effects of prior authorization policies on medicaid-enrolled children’s use of antipsychotic medications: Evidence from two mid-Atlantic states. Journal of Child and Adolescent Psychopharmacology, 24, 374–381. https://doi.org/10.1089/cap.2014.0008
Steinsbekk, S., Berg-Nielsen, T. S., & Wichstrøm, L. (2013). Sleep disorders in preschoolers: Prevalence and comorbidity with psychiatric symptoms. Journal of Developmental and Behavioral Pediatrics, 34, 633–641.
Sujan, A. C., Rickert, M. E., Öberg, A., Quinn, P. D., Hernández-Díaz, S., Almqvist, C., et al. (2017). Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring. JAMA, 317, 1553–1562. https://doi.org/10.1001/jama.2017.3413
The MTA Cooperative Group. (1999). A 14 month randomised clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073–1086.
Van der Heijden, K. B., Smits, M. G., Van Someren, E., Ridderinkhof, K. R., & Gunning, W. B. (2007). Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 233–241.
van der Veen-Mulders, L., van den Hoofdakker, B. J., Nauta, M. H., Emmelkamp, P., & Hoekstra, P. J. (2017). Methylphenidate has superior efficacy over parent–child interaction therapy for preschool children with disruptive behaviors. Journal of Child and Adolescent Psychopharmacology, 28(1), 66–73.
Webster-Stratton, C. (2011). Combining parent and child training for young children with ADHD. Journal of Clinical Child and Adolescent Psychology, 40, 191–203. https://doi.org/10.1080/15374416.2011.546044
Webster-Stratton, C., Reid, M. J., & Hammond, M. (2004). Treating children with early-onset conduct problems: intervention outcomes for parent, child, and teacher training. Journal of Clinical Child and Adolescent Psychology, 33, 105–124.
Weiss, M. D., Wasdell, M. B., Bomben, M. M., Rea, K. J., & Freeman, R. D. (2006). Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 512–519.
West, L., Brunssen, S. H., & Waldrop, J. (2009). Review of the evidence for treatment of children with autism with selective serotonin reuptake inhibitors. Journal for Specialists in Pediatric Nursing, 14, 183–191. https://doi.org/10.1111/j.1744-6155.2009.00196.x
Wichstrøm, L., Berg-Nielsen, T. S., Angold, A., Egger, H. L., Solheim, E., & Sveen, T. H. (2012). Prevalence of psychiatric disorders in preschoolers. Journal of Child Psychology and Psychiatry, 53, 695–705.
Wigal, S. B., Gupta, S., Greenhill, L., Posner, K., Lerner, M., Steinhoff, K., et al. (2007). Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 17, 153–164.
Wigal, T., Greenhill, L., Chuang, S., McGough, J., Vitiello, B., Skrobala, A., et al. (2006). Safety and tolerability of methylphenidate in preschool children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 1294–1303.
Yeh, M., Hough, R. L., McCabe, K., Lau, A., & Garland, A. (2004). Parental beliefs about the causes of child problems: Exploring racial/ethnic patterns. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 605–612.
Zero to Three. (2016). Diagnostic classification of mental and developmental disorders in infancy and early childhood (Rev. ed.). Washington, DC: Zero to Three Press.
Zito, J., Safer, D., dosReis, S., Gardner, J., Boles, M., & Lynch, F. (2000a). Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association, 283, 1025–1030.
Zito, J. M., Safer, D. J., DosReis, S., Gardner, J. F., Magder, L., Soeken, K., et al. (2003). Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatrics and Adolescent Medicine, 157, 17–25. https://doi.org/10.1001/archpedi.157.1.17
Zito, J. M., Safer, D. J., Valluri, S., Gardner, J. F., Korelitz, J. J., & Mattison, R. E. (2007). Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. Journal of Child and Adolescent Psychopharmacology, 17, 195–203.
Zito, J. M., Safer, D. J., Zuckerman, I. H., Gardner, J. F., & Soeken, K. L. (2005). Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services, 56, 157–163.
Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000b). Trends in the prescribing of psychotropic medications to preschoolers. JAMA, 283, 1025–1030. https://doi.org/10.1001/jama.283.8.1025
Zuckerman, M. L., et al. (2007). Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: A retrospective chart review. Journal of Child and Adolescent Psychopharmacology, 17, 165–174.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Finelli, J., Gleason, M.M. (2019). Psychopharmacologic Considerations in Early Childhood. In: Frankel, K.A., Harrison, J., Njoroge, W.F.M. (eds) Clinical Guide to Psychiatric Assessment of Infants and Young Children. Springer, Cham. https://doi.org/10.1007/978-3-030-10635-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-10635-5_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10634-8
Online ISBN: 978-3-030-10635-5
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)